HPV vaccine delivery study in Ethiopia
Part of Infections clinical trials.
This study looks at how HPV vaccines are given to girls in Ethiopia, aiming to improve access and uptake. It involves interviews and surveys with girls and their caregivers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Girls aged 9 to 14 years old
- Caregivers must be 18 years or older and be the parent or legal guardian
- For exit interviews, girls must have received HPV vaccination or other youth health services on the day of recruitment
- Must agree to be interviewed and audio-recorded
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to best deliver the HPV vaccine in Cameroon. You can join if you are a key person helping with the vaccine program, and you agree to join the study.
This study aims to help prevent HPV-related cancers by increasing HPV vaccination rates in rural areas. It is for parents of 8- to 12-year-olds who have not yet completed the two-dose HPV vaccine series.
This trial offers HPV vaccination and sexual health education to 10-13 year old students and out-of-school youth in Laos. It aims to improve health knowledge and vaccination rates.
This trial tests a way to give HPV vaccines along with routine childhood immunizations in Ghana. It aims to protect against HPV, a virus that can cause cervical cancer, by making it easier to get the vaccine.
This study combines HPV vaccination with other health services for young people in Ivory Coast. It aims to protect adolescents against HPV, which can cause cancer, while also checking their overall health and well-being.
This study tests a program that helps adolescent girls and their caregivers learn about the HPV vaccine together. It aims to make it easier for families to decide whether to get the vaccine, which protects against certain cancers and other diseases.
Hear when a new Papillomavirus Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.